All News #Library
Biotech
Avixgen, Dx&Vx unit, licenses out ACP platform for $360M to US
18 Aug 2025 //
PR NEWSWIRE
Dx&Vx Inks $220M Deal for mRNA Cancer Vaccine with U.S. Biotech
30 Jul 2025 //
PR NEWSWIRE
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
28 May 2025 //
PR NEWSWIRE
Dx&Vx Develops Vaccine For Next-Gen Infectious Disease Response
13 Jan 2025 //
PR NEWSWIRE
DX&VX Chosen for Korea`s First ARPA-H Vaccine Storage Project
01 Nov 2024 //
PR NEWSWIRE

Market Place
Sourcing Support